Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic graft-versus-host disease.

Stephanie J Lee1, Georgia Vogelsang, Mary E D Flowers

  • 1Department of Adult Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. stephanie_lee@dfci.harvard.edu

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|April 30, 2003
PubMed
Summary

Chronic graft-versus-host disease (GVHD) is a serious complication after stem cell transplants. Severe chronic GVHD requires intensive treatment and impacts survival, while mild cases are manageable.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.

Blood advances·2024
Same author

Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival.

Transplantation and cellular therapy·2023
Same author

Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation.

American journal of hematology·2022
Same author

Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.

Blood·2022
Same author

Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin.

Bone marrow transplantation·2021
Same author

Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival.

Blood advances·2021

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Chronic graft-versus-host disease (GVHD) is a significant post-transplant complication.
  • Its severity ranges from mild, manageable cases to severe, life-threatening conditions.
  • GVHD impacts long-term survival and quality of life for transplant recipients.

Purpose of the Study:

  • To review current understanding of chronic GVHD pathogenesis.
  • To outline clinical risk factors, classification, and organ manifestations.
  • To summarize available treatments and ongoing clinical trials for prevention and treatment.

Main Methods:

  • Literature review of pathogenesis and clinical aspects.
  • Analysis of classification systems and organ involvement.

Related Experiment Videos

  • Compilation of data on current and investigational therapies.

    • Main Results:

    • Chronic GVHD pathogenesis is complex, involving immune dysregulation.
    • Risk factors and clinical presentation vary widely.
    • Treatment strategies differ based on severity, with ongoing research for novel therapies.

    Conclusions:

    • Understanding chronic GVHD is crucial for effective management.
    • Tailored treatment approaches are necessary for different disease severities.
    • Further research and clinical trials are essential to improve outcomes.